Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9773 |
High Similarity |
NPD1549 |
Phase 2 |
0.9697 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9697 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9398 |
High Similarity |
NPD1510 |
Phase 2 |
0.9389 |
High Similarity |
NPD1240 |
Approved |
0.9248 |
High Similarity |
NPD1607 |
Approved |
0.9071 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9071 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9 |
High Similarity |
NPD1511 |
Approved |
0.8905 |
High Similarity |
NPD2796 |
Approved |
0.8873 |
High Similarity |
NPD1512 |
Approved |
0.8828 |
High Similarity |
NPD7411 |
Suspended |
0.8786 |
High Similarity |
NPD3750 |
Approved |
0.8767 |
High Similarity |
NPD1934 |
Approved |
0.8759 |
High Similarity |
NPD4380 |
Phase 2 |
0.8707 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD7075 |
Discontinued |
0.8658 |
High Similarity |
NPD3749 |
Approved |
0.8649 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8633 |
High Similarity |
NPD1551 |
Phase 2 |
0.8601 |
High Similarity |
NPD6799 |
Approved |
0.8581 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD7819 |
Suspended |
0.8571 |
High Similarity |
NPD1203 |
Approved |
0.8456 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8429 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8409 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.838 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8323 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8322 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1243 |
Approved |
0.831 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8273 |
Intermediate Similarity |
NPD943 |
Approved |
0.8261 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8209 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8205 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8205 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8163 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8151 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8134 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8106 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8105 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8054 |
Intermediate Similarity |
NPD920 |
Approved |
0.805 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8041 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8028 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8014 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7986 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7986 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7986 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7872 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD2798 |
Approved |
0.784 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7808 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7793 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD2797 |
Approved |
0.777 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7746 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7744 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7704 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7687 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7681 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7671 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD919 |
Approved |
0.7643 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7643 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD411 |
Approved |
0.7609 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7607 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7594 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7578 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7562 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7554 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7468 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD17 |
Approved |
0.7455 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7399 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD74 |
Approved |
0.7348 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7194 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD5889 |
Approved |
0.717 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8312 |
Approved |
0.707 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7051
|
Intermediate Similarity |
NPD7212 |
Phase 2 |